Logo image of SCHN

SCHNITZER STEEL INDS INC-A (SCHN) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SCHN - US8068821060 - Common Stock

33.2 USD
-0.19 (-0.57%)
Last: 8/31/2023, 8:18:19 PM
33.2 USD
0 (0%)
After Hours: 8/31/2023, 8:18:19 PM

SCHN Key Statistics, Chart & Performance

Key Statistics
Market Cap906.73M
Revenue(TTM)3.06B
Net Income(TTM)10.38M
Shares27.31M
Float25.28M
52 Week High36.64
52 Week Low25.96
Yearly DividendN/A
Dividend Yield2.52%
EPS(TTM)0.87
PE38.16
Fwd PE20.34
Earnings (Next)10-23
IPO1993-11-16
Sector
GICS SectorMaterials
GICS IndustryMetals & Mining
GICS IndustryGroupMaterials
GICS SubIndustrySteel
SCHN short term performance overview.The bars show the price performance of SCHN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

SCHN long term performance overview.The bars show the price performance of SCHN in the last 1, 2 and 3 years. 1 year 2 years 3 years 0.5 1 1.5 2 2.5

The current stock price of SCHN is 33.2 USD. In the past month the price decreased by -2.78%. In the past year, price increased by 2.88%.

SCHNITZER STEEL INDS INC-A / SCHN Daily stock chart

SCHN Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to SCHN. When comparing the yearly performance of all stocks, SCHN is one of the better performing stocks in the market, outperforming 74.13% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

SCHN Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SCHN. The financial health of SCHN is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SCHN Financial Highlights

Over the last trailing twelve months SCHN reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS decreased by -88.18% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.34%
ROA 0.56%
ROE 1.11%
Debt/Equity 0.37
Chartmill High Growth Momentum
EPS Q2Q%-74.13%
Sales Q2Q%-19.85%
EPS 1Y (TTM)-88.18%
Revenue 1Y (TTM)159.95%

SCHN Forecast & Estimates

9 analysts have analysed SCHN and the average price target is 35.7 USD. This implies a price increase of 7.53% is expected in the next year compared to the current price of 33.2.

For the next year, analysts expect an EPS growth of -87.36% and a revenue growth -15.3% for SCHN


Analysts
Analysts48.89
Price Target35.7 (7.53%)
EPS Next Y-87.36%
Revenue Next Year-15.3%

SCHN Ownership

Ownership
Inst Owners82.28%
Ins Owners2.41%
Short Float %N/A
Short RatioN/A

About SCHN

Company Profile

SCHN logo image Schnitzer Steel Industries, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company is headquartered in Boston, Massachusetts and currently employs 3,471 full-time employees. The firm is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The firm also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).

Company Info

SCHNITZER STEEL INDS INC-A

22 Boston Wharf Road, 7Th Floor

Boston MASSACHUSETTS 97201 US

CEO: Tamara L. Lundgren

Employees: 3471

SCHN Company Website

Phone: 15032249900.0

SCHNITZER STEEL INDS INC-A / SCHN FAQ

What does SCHN do?

Schnitzer Steel Industries, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company is headquartered in Boston, Massachusetts and currently employs 3,471 full-time employees. The firm is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The firm also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).


What is the stock price of SCHNITZER STEEL INDS INC-A today?

The current stock price of SCHN is 33.2 USD. The price decreased by -0.57% in the last trading session.


What is the dividend status of SCHNITZER STEEL INDS INC-A?

SCHNITZER STEEL INDS INC-A (SCHN) has a dividend yield of 2.52%. The yearly dividend amount is currently 0.


What is the ChartMill technical and fundamental rating of SCHN stock?

SCHN has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the expected growth for SCHN stock?

The Revenue of SCHNITZER STEEL INDS INC-A (SCHN) is expected to decline by -15.3% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the market cap for SCHNITZER STEEL INDS INC-A?

SCHNITZER STEEL INDS INC-A (SCHN) has a market capitalization of 906.73M USD. This makes SCHN a Small Cap stock.


What is the next earnings date for SCHN stock?

SCHNITZER STEEL INDS INC-A (SCHN) will report earnings on 2023-10-23, before the market open.